Association between xrcc3 rs861539 polymorphism and the risk of ovarian cancer: meta-analysis and trial sequential analysis

HIGHLIGHTS

  • who: Siya Hu et al. from the Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine, Harbin, China have published the article: Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis, in the Journal: BioMed Research International of 25/03/2022
  • what: The studies included in this metaanalysis need to meet the following criteria: focusing on the association of XRCC3 polymorphism rs861539 with ovarian cancer risk, case-control studies, and_(3) providing sufficient information on genotype frequency in the case and control groups. The main reasons . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?